Introducing Previda®-DX, an advanced preimplantation genetic test that screens embryos for inherited genetic disorders. Tailored to couples with a family history of specific monogenic/single gene defects (PGT-M) and chromosomal structural rearrangements (PGT-SR), Previda®-DX assists your IVF team in selecting a healthy embryo for transfer. Trust in the power of precision genetics to shape your path to a healthy family.

Evaluate your family history risk

If a single gene disorder runs in your family, you can assess your child’s risk of inheriting the condition before implantation. PGT-M enables you to make informed decisions based on genetic insights.

Assess unexplained infertility

Recurrent miscarriages may be attributed to chromosomal structural rearrangements. Prior to transfer, our PGT-SR screens embryos for these abnormalities, shedding light on unexplained infertility.

Select healthy embryo for transfer

With the results from our tests, your physician can choose an embryo that is free of inherited genetic defects or unbalanced rearrangements. This selection maximizes your chance of a successful and healthy pregnancy.


Your Healthcare Provider

Request test and provide genetic records

Draw blood from parents

Request test and provide genetic records

Your Progenesis Team

Review gene report and design test

Optimize test with parental DNA to confirm mutation

Final test performed on embryo biopsy



At Progenesis, you are at the heart of everything we do. Your questions and concerns matter to us, and we’re here to provide the answers and support you need. Your journey to a healthy family starts with us.